살생물제 시장 : 용도, 유형, 유효 성분, 형태, 작용 형태별 - 세계 예측(2025-2032년)

The Biocides Market is projected to grow by USD 13.82 billion at a CAGR of 4.66% by 2032.

A strategic introduction to the evolving biocides landscape that frames regulatory pressure, supply chain resilience and innovation imperatives for decision-makers

Biocides occupy a pivotal role across industrial and consumer value chains, serving to protect products, processes, infrastructure and public health from microbial and pest threats. In recent years the sector has been shaped by a confluence of regulatory tightening, heightened sustainability expectations, and evolving end-user performance requirements. These forces are accelerating reformulation, expanding demand for specialty chemistries, and intensifying scrutiny across the full lifecycle of active ingredients and formulated products.

Against this backdrop, manufacturers and downstream users face mounting pressure to reconcile efficacy, safety, compatibility with substrates, and environmental footprint while navigating heightened compliance complexity. Supply chain vulnerabilities exposed during recent global disruptions have elevated the importance of procurement resilience and regional manufacturing capacity. Meanwhile, technology-driven monitoring and service models are creating opportunities to deliver differentiated value beyond commodity chemistries, enabling providers to position themselves as partners in contamination control, asset protection and regulatory compliance.

This executive summary frames the critical commercial and operational implications of these trends. It synthesizes structural shifts, segmentation dynamics, regional contours and strategic options that can guide senior leaders toward effective investment, innovation and go-to-market choices in a rapidly changing biocides landscape.

Identifying the major transformative shifts reshaping competitive dynamics, formulation strategies, and go-to-market models across the biocides ecosystem

The biocides landscape is undergoing several transformative shifts that are redefining competition and customer expectations. Regulatory regimes are becoming more prescriptive on ingredient approvals and labeling, prompting manufacturers to accelerate substitution pathways and invest in toxicology and exposure science. Concurrently, sustainability and circularity considerations are driving demand for lower-legacy-impact active ingredients, reduced solvent loads in formulations, and packaging innovations that minimize waste.

Technological innovation is another major vector of change. Advances in active chemistry, controlled-release technologies, and surface-functionalization approaches are enabling longer-lasting protection with lower raw material inputs. At the same time, digitization of monitoring and remote diagnostics is creating recurring revenue streams through service-oriented contracts, shifting value capture away from one-time product transactions to outcome-based partnerships.

Market access dynamics have also shifted, with buyers placing a premium on supply chain transparency, traceability and local sourcing. These expectations are prompting strategic reshoring, the formation of tighter supplier alliances, and investments in regional manufacturing footprints. Taken together, these shifts are encouraging incumbent players and new entrants to re-evaluate portfolio composition, invest in differentiated capabilities, and accelerate stakeholder engagement across regulatory, customer and civic ecosystems.

Assessing the cumulative operational and commercial impacts of new United States tariff measures on biocide supply chains, procurement strategies, and product pricing dynamics

The introduction of new tariff measures in the United States during 2025 has exerted a material influence on cost structures, sourcing choices and procurement strategies for firms participating in the biocides value chain. Tighter border measures and higher duties on specific chemical classes and precursor materials have increased landed costs for import-dependent manufacturers and accelerated a search for alternative supply sources and substitutes. In response, many producers have revisited their supplier portfolios to reduce exposure to single-origin risk and to shorten lead times through regional distribution centers.

These tariff dynamics have also influenced inventory and pricing strategies. Procurement teams have adopted more dynamic hedging of raw material purchases, extended safety stock for critical intermediates, and negotiated longer-term purchase agreements with strategic suppliers to mitigate price volatility. For specialty formulators, the incremental cost pressure has prompted a focus on value-added differentiation-such as higher-efficacy low-dose formulations, multifunctional chemistries, and bundled service offerings-that can sustain margins despite higher input costs.

Regulatory compliance and administrative burden have risen in parallel, adding to the cost of market entry for new products and increasing the importance of robust customs and trade-compliance functions. Collectively, these effects underscore the need for agility in sourcing, stronger commercial collaboration across the supply chain, and targeted investments in production flexibility to preserve competitiveness in tariff-affected markets.

Deep segmentation insights connecting application, chemistry, form and mode of action to strategic product positioning and commercial pathways across end-use markets

Segment dynamics in the biocides sector are best understood through an integrated lens that connects application, type, active ingredient, form and mode of action. On the application side, Food & Beverage protection spans baked goods, beverages including alcoholic beverages, bottled water and soft drinks, dairy products, and meat and poultry processing-each sub-application imposes distinct hygiene standards, compatibility and residue constraints. Paints & Coatings applications differentiate across architectural, marine and protective coatings, with protective coatings further divided between automotive and industrial protective uses, creating distinct performance and regulatory requirements. Paper & Pulp is segmented into packaging paperboard, printing and writing paper, and tissue paper, where preservative needs reflect substrate sensitivity and end-use exposure. The Pharmaceuticals & Personal Care domain covers cosmetics, personal care and pharmaceuticals, with personal care splitting into hair care, oral care and skin care categories that impose elevated safety and consumer-safety expectations. Water Treatment divides into industrial and municipal streams; industrial applications include cooling water and wastewater systems, while municipal needs encompass drinking water treatment and municipal wastewater management. Wood Processing & Textiles covers textile preservation and wood preservation, with the latter further differentiated by impregnation and surface treatment techniques that drive formulation choices.

In parallel, type-level segmentation distinguishes disinfectants, pest control agents and preservatives. Disinfectants split into non-oxidizing biocides and oxidizing biocides; non-oxidizing chemistries such as biguanides, phenolic compounds and quaternary ammonium compounds are preferred where material compatibility and lower corrosion are priorities, whereas oxidizing classes like chlorine-based agents and peroxygens are selected for high-throughput sterilization and rapid broad-spectrum activity. Pest control agents include fungicides, insecticides and rodenticides, each with distinct exposure pathways and environmental considerations. Preservatives center on isothiazolinones, organosulfur chemistries and phenolic compounds, and are particularly scrutinized for long-term human health and environmental fate profiles. Active-ingredient segmentation highlights chlorine-based agents, isothiazolinones, metal-based options such as copper and silver, organosulfur, phenolic compounds and quaternary ammonium compounds, with metal-based actives increasingly evaluated for targeted antimicrobial applications. Form considerations-granule, liquid, powder and tablet-impact dosing logistics, shelf-life and operator safety, while mode-of-action segmentation between non-oxidizing and oxidizing approaches informs compatibility and monitoring requirements.

These intersecting segmentations influence commercialization pathways: stringent regulatory and consumer-safety constraints make pharmaceutical, personal care and food applications high-barrier and high-value, while industrial water treatment and protective coatings reward longevity and cost-efficiency. Formulators and distributors must therefore tailor go-to-market strategies and technical support to the specific performance, compliance and handling considerations within each combined segment.

Key regional dynamics and commercial drivers across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine access, compliance and growth trajectories

Geographic dynamics materially shape demand patterns, regulation, supply chains and innovation trajectories across the biocides sector. In the Americas, demand is driven by infrastructure modernization, strict food-safety protocols and a significant industrial base that relies on robust water treatment and protective coatings; the region also shows heightened sensitivity to trade policy shifts and supply chain resilience, leading to greater interest in domestic production and near-shoring.

Europe, the Middle East and Africa present a diverse regulatory and commercial landscape. The European market is characterized by some of the most rigorous regulatory frameworks for biocidal approvals and environmental safety, which has catalyzed substitution, reformulation and investment in safer chemistries. The Middle East is marked by rapid industrial development and growing municipal water needs, while parts of Africa are experiencing increasing demand for simple, durable solutions in public health and agricultural pest control, often coupled with constraints in regulatory enforcement and distribution infrastructure.

Asia-Pacific remains a major manufacturing and consumption hub, with large downstream industries in textiles, wood processing, food and beverage and industrial water treatment. Regulatory regimes within the region vary considerably, creating opportunities for both global suppliers and strong regional players. Rapid urbanization, expanding industrial capacity, and ongoing investment in water infrastructure are persistent demand drivers, while cost-competitive raw material supply and established chemical production ecosystems make the region central to many global supply chains. Comparative analysis across these regions highlights that regulatory clarity, infrastructure investment and supply chain strategy are primary determinants of market entry and scaling choices.

Corporate strategies and capability differentiators that industry leaders are deploying to secure regulatory access, customer loyalty and resilient supply chains

Leading firms in the biocides arena are distinguishing themselves through concentrated investments in research and development, strategic partnerships and selective portfolio reshaping. Companies with robust R&D pipelines are advancing lower-impact active chemistries and delivery systems that improve efficacy at reduced dosages, while others pursue acquisition strategies to complement competencies in niche application areas such as water treatment analytics or specialty preservatives for personal care.

Strategic collaboration with downstream users and service providers is becoming more common, enabling suppliers to offer bundled solutions that combine formulation expertise, compliance support and performance monitoring. Firms that can demonstrate strong regulatory dossiers, supply-chain traceability and credible sustainability credentials are gaining preferential access to large industrial and institutional customers. At the same time, regional players are leveraging localized manufacturing and regulatory familiarity to secure share in domestic markets, particularly in regions where local approval processes or distribution networks favor established relationships.

Operational excellence remains a competitive differentiator; companies that invest in flexible manufacturing, digital quality control and robust trade-compliance functions are better positioned to respond to rapid regulatory changes and tariff-induced cost pressures. Overall, successful companies balance near-term commercial responsiveness with long-term investments in safer chemistry, circularity and digital-enabled service models.

Actionable recommendations for leaders to align product portfolios, supply chains, and commercial models with regulatory, sustainability, and customer-focused imperatives

To capitalize on emerging opportunities and mitigate escalating risks, industry leaders should prioritize a set of targeted actions that are both practical and high-impact. First, accelerate reformulation programs that replace high-concern ingredients with lower-impact alternatives while preserving efficacy and substrate compatibility; this reduces regulatory exposure and aligns product portfolios with buyer sustainability mandates. Second, diversify sourcing and invest in regional production or toll-manufacturing relationships to reduce trade-risk exposure and shorten lead times, thereby stabilizing operations against tariff volatility and logistics disruptions.

Third, develop outcome-oriented commercial models that combine product supply with monitoring, maintenance and compliance services to create recurring revenue streams and deepen customer relationships. Fourth, strengthen regulatory and trade-compliance capabilities, including advanced data management for dossier preparation, proactive engagement with regulators and scenario planning for rapid policy shifts. Fifth, prioritize digital investments in quality assurance, traceability and remote monitoring to enable performance guarantees and improve operational efficiency. Finally, pursue selective partnerships and acquisitions that add technical capabilities in specialty chemistries, analytical services or regional market access rather than pursuing broad scale at the expense of technical differentiation. Executing on these recommendations requires cross-functional governance that aligns R&D, commercial, regulatory and supply-chain functions toward shared strategic objectives.

A transparent research methodology combining primary stakeholder interviews, secondary synthesis and analytical triangulation to generate actionable strategic insights

The research synthesis underpinning this executive summary relied on a blended methodology that integrates primary qualitative engagement and structured secondary analysis. Primary research included interviews with formulators, procurement leads within heavy industrial and food-processing companies, regulatory specialists and third-party service providers to capture first-hand perspectives on compliance, efficacy requirements and customer procurement behavior. These engagements were designed to elicit practical constraints and strategic priorities rather than to generate quantitative market estimates.

Secondary analysis comprised a systematic review of regulatory announcements, scientific literature on active ingredients and publicly available corporate disclosures to map product portfolios, innovation trends and supply-chain configurations. Triangulation across sources ensured that thematic conclusions - such as the move toward lower-impact chemistries, the rise of service-based models, and the operational responses to tariff pressures - are supported by convergent evidence from independent stakeholders.

Analytical techniques included segmentation cross-mapping to align application needs with chemistry and form choices, scenario analysis for tariff and supply-disruption pathways, and capability-gap assessment for supplier and downstream actors. The approach emphasizes pragmatic insight generation and decision-relevant recommendations while maintaining transparency about the qualitative basis of several strategic conclusions.

A concise conclusion emphasizing the strategic priorities and integrated actions necessary for durable competitive advantage in the evolving biocides sector

The cumulative insight from this analysis underscores that the biocides sector is at an inflection point where regulatory, commercial and technological forces converge to reshape competitive advantage. Firms that respond by investing in safer and higher-performing chemistries, building resilient regional supply chains, and adopting digital-enabled service models will be better positioned to capture higher-value opportunities and to withstand policy-driven cost pressures.

Concurrent operational actions-such as strengthening trade-compliance, diversifying suppliers, and pursuing targeted partnerships-will reduce exposure to tariff shocks while supporting continuity of supply. Importantly, success requires a holistic approach that connects product innovation with downstream integration, compliance readiness, and customer-focused service delivery. Organizations that can align these elements will secure preferential access to regulated and safety-sensitive applications and build differentiated, defensible market positions.

In sum, the pathway forward favors agility, technical differentiation and strategic collaboration. Executives who prioritize these areas will be able to convert emerging industry dynamics into sustainable commercial advantage.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Rising demand for sustainable bio-based antimicrobial formulations in personal care products
• 5.2. Integration of nanotechnology-enabled biocide coatings in medical device manufacturing for infection control
• 5.3. Stringent global regulations driving innovation in low-toxicity biocide substitutes for water treatment applications
• 5.4. Growing adoption of advanced oxidation processes combined with biocides for industrial effluent disinfection
• 5.5. Increased focus on microbial resistance monitoring influencing development of combination biocide therapies
• 5.6. Shift towards renewable feedstock-derived biocidal agents to reduce environmental impact in agriculture

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biocides Market, by Application

• 8.1. Food & Beverage
  • 8.1.1. Baked Goods
  • 8.1.2. Beverages
    • 8.1.2.1. Alcoholic Beverages
    • 8.1.2.2. Bottled Water
    • 8.1.2.3. Soft Drinks
  • 8.1.3. Dairy Products
  • 8.1.4. Meat & Poultry
• 8.2. Paints & Coatings
  • 8.2.1. Architectural
  • 8.2.2. Marine
  • 8.2.3. Protective
    • 8.2.3.1. Automotive
    • 8.2.3.2. Industrial Protective
• 8.3. Paper & Pulp
  • 8.3.1. Packaging Paperboard
  • 8.3.2. Printing & Writing Paper
  • 8.3.3. Tissue Paper
• 8.4. Pharmaceuticals & Personal Care
  • 8.4.1. Cosmetics
  • 8.4.2. Personal Care
    • 8.4.2.1. Hair Care
    • 8.4.2.2. Oral Care
    • 8.4.2.3. Skin Care
  • 8.4.3. Pharmaceuticals
• 8.5. Water Treatment
  • 8.5.1. Industrial
    • 8.5.1.1. Cooling Water
    • 8.5.1.2. Wastewater
  • 8.5.2. Municipal
    • 8.5.2.1. Drinking Water
    • 8.5.2.2. Wastewater
• 8.6. Wood Processing & Textiles
  • 8.6.1. Textile Preservation
  • 8.6.2. Wood Preservation
    • 8.6.2.1. Impregnation
    • 8.6.2.2. Surface Treatment

9. Biocides Market, by Type

• 9.1. Disinfectants
  • 9.1.1. Non-Oxidizing Biocides
    • 9.1.1.1. Biguanides
    • 9.1.1.2. Phenolic Compounds
    • 9.1.1.3. Quaternary Ammonium Compounds
  • 9.1.2. Oxidizing Biocides
    • 9.1.2.1. Chlorine Based
    • 9.1.2.2. Peroxygens
• 9.2. Pest Control Agents
  • 9.2.1. Fungicides
  • 9.2.2. Insecticides
  • 9.2.3. Rodenticides
• 9.3. Preservatives
  • 9.3.1. Isothiazolinones
  • 9.3.2. Organosulfur
  • 9.3.3. Phenolic Compounds

10. Biocides Market, by Active Ingredient

• 10.1. Chlorine Based
• 10.2. Isothiazolinones
• 10.3. Metal Based
  • 10.3.1. Copper
  • 10.3.2. Silver
• 10.4. Organosulfur
• 10.5. Phenolic Compounds
• 10.6. Quaternary Ammonium Compounds

11. Biocides Market, by Form

• 11.1. Granule
• 11.2. Liquid
• 11.3. Powder
• 11.4. Tablet

12. Biocides Market, by Mode Of Action

• 12.1. Non-Oxidizing
  • 12.1.1. Biguanides
  • 12.1.2. Phenolic Compounds
  • 12.1.3. Quaternary Ammonium Compounds
• 12.2. Oxidizing
  • 12.2.1. Chlorine Based
  • 12.2.2. Peroxygens

13. Biocides Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Biocides Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Biocides Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Lonza Group AG
  • 16.3.2. LANXESS AG
  • 16.3.3. BASF SE
  • 16.3.4. Solvay SA
  • 16.3.5. Dow Inc.
  • 16.3.6. Ecolab Inc.
  • 16.3.7. Akzo Nobel N.V.
  • 16.3.8. Evonik Industries AG
  • 16.3.9. Eastman Chemical Company
  • 16.3.10. Ashland Global Holdings Inc.